Plate A |
[Not Available]. |
2016 |
Praxis (Bern 1994) |
pmid:27606919
|
Huh CW et al. |
Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates. |
2016 |
PLoS ONE |
pmid:27588679
|
Watanabe M et al. |
Saturated fatty acids and fatty acid esters promote the polymorphic transition of clarithromycin metastable form I crystal. |
2016 |
Int J Pharm |
pmid:27553780
|
Nagashima A et al. |
Clarithromycin Suppresses Chloride Channel Accessory 1 and Inhibits Interleukin-13-Induced Goblet Cell Hyperplasia in Human Bronchial Epithelial Cells. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27550358
|
Lin LC et al. |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. |
2016 |
World J. Gastroenterol. |
pmid:27340362
|
Abd-Elsalam S et al. |
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience. |
2016 |
Medicine (Baltimore) |
pmid:27310977
|
De Francesco V et al. |
Two-week Triple Therapy with either Standard or High-dose Esomeprazole for First-line H. pylori Eradication. |
2016 |
J Gastrointestin Liver Dis |
pmid:27308644
|
Zollner-Schwetz I et al. |
Primary resistance of Helicobacter pylori is still low in Southern Austria. |
2016 |
Int. J. Med. Microbiol. |
pmid:27134190
|
Georgopoulos SD et al. |
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area. |
2016 |
Eur. J. Intern. Med. |
pmid:27134145
|
Kim JS et al. |
Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial. |
2016 |
Gut Liver |
pmid:27114421
|
Manniello MD et al. |
Aerodynamic properties, solubility and in vitro antibacterial efficacy of dry powders prepared by spray drying: Clarithromycin versus its hydrochloride salt. |
2016 |
Eur J Pharm Biopharm |
pmid:27106605
|
Seyama S et al. |
Clarithromycin Resistance Mechanisms of Epidemic β-Lactamase-Nonproducing Ampicillin-Resistant Haemophilus influenzae Strains in Japan. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26953210
|
Ji Z et al. |
The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China. |
2016 |
Medicine (Baltimore) |
pmid:26937912
|
Murakami K et al. |
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. |
2016 |
Gut |
pmid:26935876
|
Park JY et al. |
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA. |
2016 |
Dig. Dis. Sci. |
pmid:26923948
|
Trac MH et al. |
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. |
2016 |
CMAJ |
pmid:26903359
|
Wong AY et al. |
Cardiovascular outcomes associated with use of clarithromycin: population based study. |
2016 |
BMJ |
pmid:26768836
|
Hirama T et al. |
PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates. |
2016 |
J. Clin. Microbiol. |
pmid:26739154
|
Radheshi E et al. |
Postmortem diagnosis of anaphylaxis in presence of decompositional changes. |
2016 |
J Forensic Leg Med |
pmid:26735898
|
Hollitt A et al. |
Cat scratch disease of the parotid gland. |
2016 |
Arch. Dis. Child. |
pmid:26403943
|